Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. (formerly Ruthigen, Inc.) on July 7, 2015. The report addresses the completion of a previously announced Agreement and Plan of Merger dated March 13, 2015, and the implementation of a reverse stock split.
Key Financial Metrics
The filing does not provide specific financial data regarding revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate structural changes and share count updates.
Material Changes
- Merger Completion: On June 15, 2015, the Company completed the merger with Pulmatrix Operating Company (formerly Pulmatrix Inc.).
- Reverse Stock Split: A 1-for-2.5 reverse stock split of issued and outstanding common stock became effective.
- Share Count: Following these events, the Company had 14,515,673 shares of common stock outstanding.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the confirmation of the merger and stock split execution.
Investor Verification Checklist
- Verify the post-split share count of 14,515,673 shares.
- Confirm the effective date of the merger (June 15, 2015) and the reverse stock split.
- Review the original March 13, 2015 Agreement and Plan of Merger for terms not detailed in this 8-K.